Login

FREE TRIAL  Receive 30 days of no-obligation access. SIGN UP

Home

Focus On ACIP

ACIP Members May Spar With FDA Officials Over COVID Shots At Next Meeting

The Centers for Disease Control and Prevention’s vaccine advisory committee is set to hold another contentious meeting in March, with its agenda hinting at a discussion of COVID-19 vaccines that could put its members, who include several dedicated anti-vaccine activists, at odds with FDA regulators who have declined to pull back access to the shots.

Kennedy Adds More New ACIP Members Ahead Of March Meeting

Top Story

Bhattacharya Pushes NIH-CDC Integration, Targets Lower Costs for Gene Therapies

Jay Bhattacharya, who is serving as both director of the National Institutes of Health and acting director of the Centers for Disease Control and Prevention, said the two agencies should be more integrated in an interview Friday (Feb. 27), arguing that closer alignment would speed the translation of federally funded research into large-scale public health deployment.

Latest News

The World Professional Association for Transgender Health, the American Academy of Pediatrics and the Endocrine Society have each filed lawsuits against the Federal Trade Commission, seeking to block the FTC’s investigations of the organizations and alleging they are being retaliated against for protected speech in support of gender-affirming care for patients under age 18.

House Education & the Workforce Committee Republicans are working to schedule their first hearing with HHS Secretary Robert F. Kennedy Jr., GOP staff told Inside Health Policy late Monday (March 2).

A coalition of accountable care organizations (ACOs) is urging CMS to incorporate the voluntary alignment framework used in the ACO REACH model into the Medicare Shared Savings Program (MSSP), arguing the change could connect more than half a million additional seniors to coordinated care and generate more than $100 million in annual Medicare savings.

FDA on Thursday (Feb. 26) issued its second approval for drug under the Commissioner’s National Priority Review Voucher program, in this case a new indication for Boehringer Ingelheim’s lung cancer drug Hernexeos (zongertinib).

CMS is eyeing artificial intelligence tools that would improve the accuracy of Medicare Advantage coding and hospital billing as part of the Trump administration’s future CRUSH proposed rule, which will seek to stop and prevent fraud in government health insurance programs.

The One Big Beautiful Bill Act will strip about $665 billion from Medicaid budgets nationwide from 2025-2034, and states that expanded Medicaid under the Affordable Care Act and rely on provider taxes or state-directed payments for their Medicaid funding -- like Arkansas, Iowa, New York and California -- expect to see the largest declines, according to a RAND analysis released Thursday (Feb. 26) that offers state-level estimates of key Medicaid provisions in the law.